References
- Hou W, Zhang W, Jin R, et al. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infect Dis. 2020;52(7):498–505.
- Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID-19-positive patients. Int J Dermatol. 2020;59(8):1028–1029.
- Shors AR. Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection. JAAD Case Rep. 2020;6(7):656–657.
- Elsaie ML, Youssef EA, Nada HA. Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther. 2020:e13666. DOI:10.1111/dth.13666
- Elsaie ML, Nada HA. Herpes Zoster (shingles) complicating the course of COVID19 infection. J Dermatolog Treat. 2020. DOI:10.1080/09546634.2020.1782823
- de Freitas Ferreira ACA, Romão TT, SIlva Macedo Y, et al. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur J Neurol. 2020. DOI:10.1111/ene.14361
- Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369(3):255–263.
- Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269–270.
- Kennedy JJ, Steain M, Slobedman B, et al. Infection and functional modulation of human monocytes and macrophages by varicella-zoster virus. J Virol. 2018;93(3):e01887–18.
- Werner RN, Nikkels AF, Marinovic B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: diagnosis. J Eur Acad Dermatol Venereol. 2017;31(1):9–19.